Bugworks Research set for pre-clinical drug trials

CARB-X was formed two years ago as a public-private partnership to tackle the rising menace of antibiotic resistance.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2RHj2ej
via IFTTT